Current Pharmacogenomics and Personalized Medicine
Title:Editorials (Pharmacogenomics in Primary Care: A Crucial Entry Point for Global Personalized Medicine?)
Volume: 10
Author(s): Gillian Bartlett, Nathalie Zgheib, Aresha Manamperi, Wei Wang, Candan Hızel, Rabia Kahveci and Yasemin Yazan
Affiliation:
Keywords: Developing countries, developing world genomics, essential medicines, genomics and international development, global personalized medicine, pharmacogenomics and primary care, primary care genomics, public health pharmacogenomics
Export Options
About this article
Cite this article as:
Bartlett Gillian, Zgheib Nathalie, Manamperi Aresha, Wang Wei, Hızel Candan, Kahveci Rabia and Yazan Yasemin, Editorials (Pharmacogenomics in Primary Care: A Crucial Entry Point for Global Personalized Medicine?), Current Pharmacogenomics and Personalized Medicine 2012; 10 (2) . https://dx.doi.org/10.2174/187569212800626430
DOI https://dx.doi.org/10.2174/187569212800626430 |
Print ISSN 1875-6921 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6913 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Synthesis of New Cyanopyridine Scaffolds and their Biological Activities
Current Organic Synthesis Molecular Targeting of Breast Cancer: Molecular Imaging and Therapy
Current Pharmaceutical Biotechnology Aromatase Inhibitors Evolution as Potential Class of Drugs in the Treatment of Postmenopausal Breast Cancer Women
Mini-Reviews in Medicinal Chemistry Preparation and Quality Control of <sup>111</sup>In-Plerixafor for Chemokine Receptor CXCR4
Recent Patents and Topics on Imaging (Discontinued) Genetic Association Studies: An Information Content Perspective
Current Genomics Advancement of Traditional Chinese Medicine in Regulation of Intestinal Flora: Mechanism-based Role in Disease Management
Recent Patents on Anti-Cancer Drug Discovery Blood-Brain Barrier and Breast Cancer Resistance Protein: A Limit to the Therapy of CNS Tumors and Neurodegenerative Diseases
Anti-Cancer Agents in Medicinal Chemistry Differential Cytotoxicity, Cellular Uptake, Apoptosis and Inhibition of BRCA1 Expression of BRCA1-Defective and Sporadic Breast Cancer Cells Induced by an Anticancer Ruthenium(II)-Arene Compound, RAPTA-EA1
Anti-Cancer Agents in Medicinal Chemistry Clinical Use of Neurophysiological Biomarkers and Self-Assessment Scales to Predict and Monitor Treatment Response for Psychotic and Affective Disorders
Current Pharmaceutical Design Application of Radiolabeled Antibodies in Targeting Therapy of Breast Cancer
Current Molecular Imaging (Discontinued) Metabolomics as a Functional Tool in Screening Gastro Intestinal Diseases: Where are we in High Throughput Screening?
Combinatorial Chemistry & High Throughput Screening Bone Marker in Women with Breast Cancer
Current Biomarkers (Discontinued) Antiangiogenesis in Myelodysplastic Syndrome
Current Cancer Drug Targets Evaluation of Hyperforin Analogues for Inhibition of 5-lipoxygenase
Medicinal Chemistry Insight into p95HER2 in Breast Cancer: Molecular Mechanisms and Targeted Therapies
Recent Patents on DNA & Gene Sequences Review: The Role of MOP and DOP Receptors in Treatment of Diarrheapredominant Irritable Bowel Syndrome
Mini-Reviews in Medicinal Chemistry Asafoetida, Natural Medicine for Future
Current Nutrition & Food Science Copper Lowering Therapy With Tetrathiomolybdate as an Antiangiogenic Strategy in Cancer
Current Cancer Drug Targets How to Advise Aspirin Use in Patients Who Need NSAIDs
Current Pharmaceutical Design Infringement of the Barriers of Cancer Via Dietary Phytoconstituents Capsaicin Through Novel Drug Delivery System
Current Drug Delivery